The firm's revenue for the quarter was up 333.0% compared to the same quarter last year. equities research analysts anticipate that Sangamo Therapeutics, Inc. will post -0.73 earnings per share for the current fiscal year. The most recent shifts in number of shares owned by institutions came on September 30, 2017 when Wasatch Advisors Inc sold 1.74 million shares from its total ownership of 5.19 million.
Analyst Thoughts About Sangamo Therapeutics, Inc. (NASDAQ:SGMO) traded down $0.05 during midday trading on Friday, reaching $16.35. About 1.21 million shares traded. Sangamo Therapeutics, Inc. has a 12 month low of $2.85 and a 12 month high of $18.40. It has outperformed by 13.08% the S&P500. (SGMO) by 9.22% based on its latest 2017Q2 regulatory filing with the SEC. Hartline Investment Corp acquired 6,325 shares as Visa Inc Class A (V)'s stock rose 5.74%. The hedge funds in our partner's database now possess: 50.83 million shares, up from 40.72 million shares in 2017Q1. Visa Inc Class A now has $257.94B valuation. The stock increased 1.30% or $0.4 during the last trading session, reaching $31.08. Visa Inc. (NYSE:V) has risen 20.29% since December 16, 2016 and is uptrending. It has outperformed by 52.65% the S&P500.
Investors sentiment decreased to 1.57 in Q2 2017. Its up 0.79, from 0.8 in 2017Q1. It fall, as 13 investors sold SGMO shares while 31 reduced holdings. 33 funds opened positions while 37 raised stakes. The number of shares now owned by investors are 83.75 mln. Weiss Multi reported 0.03% of its portfolio in Sangamo Therapeutics, Inc.
The consensus recommendation - averaging the work of 7 analysts - of 1.9 for Sangamo Therapeutics, Inc. (NASDAQ:SGMO). 1.12M are owned by D E Shaw &. (NASDAQ:SGMO). Vigilant Ltd Liability has 0.01% invested in Sangamo Therapeutics, Inc. (NASDAQ:SGMO). State Board Of Administration Of Florida Retirement System accumulated 61,070 shares or 0% of the stock.
Julian Baker decreased its stake in Sangamo Therapeutics Inc.
A number of research analysts recently weighed in on SGMO shares.
Sangamo Therapeutics, Inc, formerly Sangamo BioSciences, Inc, is a clinical-stage biotechnology company. Principal Grp reported 1.68M shares or 0.02% of all its holdings. Its down 1.96% from 11.34 million shares previously. Goldman Sachs Gru stated it has 0% of its portfolio in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) for 580,000 shares. Therefore 0 are positive. Sangamo Therapeutics has a 52 week low of $2.65 and a 52 week high of $9.45. The stock was sold at an average price of $14.37, for a total transaction of $445,470.00. Patriot National had 10 analyst reports since August 12, 2015 according to SRatingsIntel. The company was maintained on Wednesday, September 2 by Jefferies. The rating was maintained by KeyBanc Capital Markets on Tuesday, August 22 with "Hold". On Wednesday, October 19 the stock rating was downgraded by PiperJaffray to "Neutral". TheStreet downgraded the stock to "Hold" rating in Friday, October 16 report. Finally, Cowen and Company reissued a "buy" rating on shares of Sangamo Therapeutics in a research report on Tuesday, February 28th. Bnp Paribas Arbitrage has invested 0% in Sangamo Therapeutics, Inc. As per Monday, August 14, the company rating was maintained by Wedbush.
Since August 11, 2017, it had 0 insider purchases, and 4 sales for $1.02 million activity. (NASDAQ:SGMO). Barclays Public Ltd stated it has 0% in Sangamo Therapeutics, Inc. On Monday, October 2 Herberts Curt A. III sold $228,754 worth of Sangamo Therapeutics, Inc. Tiaa Cref Invest Management Limited reported 226,866 shares. Century reported 107,453 shares stake.
KB Home (NYSE:KBH) had a decrease of 1.96% in short interest. It fall, as 44 investors sold V shares while 564 reduced holdings. 38 funds opened positions while 128 raised stakes. 10,654 are held by Amica Retiree Med. (NASDAQ:SGMO). Keybank National Association Oh reported 0% of its portfolio in Sangamo Therapeutics, Inc. (NASDAQ:SGMO). Goldman Sachs Group Inc Inc has invested 0% of its portfolio in Sangamo Therapeutics, Inc. (NYSE:WPX) for 4,630 shares. Fic Capital Inc owns 960,338 shares or 3.48% of their United States portfolio. Mason Street Ltd Limited Liability Company invested 0.05% in WPX Energy, Inc. Geode Capital Management LLC now owns 633,964 shares of the biopharmaceutical company's stock worth $3,296,000 after acquiring an additional 19,331 shares in the last quarter. Fagan Assoc invested in 2.5% or 51,253 shares. (NYSE:WPX) for 290,291 shares. 60,171 are owned by Hartline Invest Corp. Jefferies Group LLC reaffirmed a "buy" rating and set a $17.00 price target on shares of Sangamo Therapeutics in a research report on Thursday. On Thursday, December 15 the stock rating was upgraded by Bank of America to "Buy". JP Morgan has "Overweight" rating and $22 target. The rating was downgraded by William Blair on Friday, December 18 to "Market Perform". The stock of Patriot National, Inc. (NYSE:V) has "Buy" rating given on Wednesday, December 16 by UBS. The firm has "Buy" rating given on Friday, December 4 by Compass Point. On Friday, September 29 the stock rating was maintained by Credit Suisse with "Neutral". 49,529 KB Home (NYSE:KBH) shares with value of $1.34 million were sold by Woram Brian J. Shares for $3.88M were sold by PRAW ALBERT Z.